Azenta (AZTA) - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1143401024
Azenta, Inc. (NASDAQ: AZTA) is a leading provider of innovative solutions in biological and chemical compound sample management for the life sciences industry. Their services cater to a diverse range of markets in North America, Africa, China, the United Kingdom, Europe, Asia Pacific, and beyond. The company operates through two main segments: Life Sciences Products and Life Sciences Services.
The Life Sciences Products division offers a wide array of solutions including automated cold storage systems, consumables, controlled rate thawing devices, as well as temperature-controlled storage and transportation options. Additionally, they provide sample management tools such as consumable vials, polymerase chain reaction plates, and state-of-the-art instruments supporting various laboratory workflows, along with informatics services.
On the other hand, the Life Sciences Services division specializes in genomic services like gene sequencing and synthesis, as well as sample repository solutions encompassing on-site and off-site sample storage, cold chain logistics, bio-processing, disaster recovery, and biospecimen procurement. The company also offers project management and consulting services tailored for genomic analysis and the care of biological samples for a broad spectrum of clients in the pharmaceutical, biotech, healthcare, and academic research sectors.
With a strong customer base that includes pharmaceutical firms, biotechnology companies, biorepositories, and research institutions, Azenta, Inc. has made a significant impact since its establishment in 1978. Formerly known as Brooks Automation, Inc., the company rebranded as Azenta, Inc. in December 2021 and is headquartered in Burlington, Massachusetts. For more information, visit their website at https://www.azenta.com.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
AZTA Stock Overview
Market Cap in USD | 2,872m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC SubIndustry | Life Sciences Tools & Services |
TER | 0.00% |
IPO / Inception | 1995-02-02 |
AZTA Stock Ratings
Growth 5y | 3.21 |
Fundamental | -34.9 |
Dividend | 0.96 |
Rel. Performance vs Sector | 1.56 |
Analysts | 3.43/5 |
Fair Price Momentum | 44.24 USD |
Fair Price DCF | 12.69 USD |
AZTA Dividends
Yield 12m | 0.00% |
Yield on Cost 5y | 0.00% |
Dividends CAGR 5y | -100.00% |
Payout Consistency | 69.2% |
AZTA Growth Ratios
Growth 12m | 19.98% |
Growth Correlation 12m | 59% |
Growth Correlation 3m | -72% |
CAGR 5y | 10.45% |
Sharpe Ratio 12m | 0.32 |
Alpha vs SP500 12m | -16.64 |
Beta vs SP500 5y weekly | 1.67 |
ValueRay RSI | 19.90 |
Volatility GJR Garch 1y | 45.59% |
Price / SMA 50 | -12.26% |
Price / SMA 200 | -7.27% |
Current Volume | 282.1k |
Average Volume 20d | 412.6k |
External Links for AZTA Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X (Twitter) • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of April 27, 2024, the stock is trading at USD 52.18 with a total of 282,124 shares traded.
Over the past week, the price has changed by +3.02%, over one month by -10.64%, over three months by -20.34% and over the past year by +28.05%.
According to ValueRays Forecast Model, AZTA Azenta will be worth about 50.2 in April 2025. The stock is currently trading at 52.18. This means that the stock has a potential downside of -3.81%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 69.6 | 33.4 |
Analysts Target Price | 58.5 | 12.1 |
ValueRay Target Price | 50.2 | -3.81 |